Dr Emily Linnane

Emily is the Scientific Manager of the CRUK Children’s Brain Tumour Centre
of Excellence and is based at the University of Cambridge, CRUK Cambridge Institute. Emily
obtained her MRes in Molecular Oncology and PhD in Cellular and Molecular Physiology at
the University of Liverpool. She later worked for an oncology biotechnology company as a
pharmacologist developing porcupine inhibitors for pancreatic cancer. In
2016 Emily joined AstraZeneca as a Postdoctoral Fellow studying intracellular uptake of
antisense oligonucleotides in KRAS mutant cancer models. Following her industrial
postdoc, Emily joined the Adsorption and Advanced Materials Laboratory at the University
of Cambridge as a Postdoctoral Research Associate working on novel nanoparticles for drug
delivery in hard-to-treat cancers. Her research interests involve novel drug development and drug delivery in paediatric brain tumours and extend to fundamental questions concerning scientific method and the philosophy of science.

Connect with us

Please get in touch with us with any comments and feedback or if you would like further information about the Centre.